Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Yes, you can legally get Wegovy online through licensed telehealth platforms that connect you with board-certified providers and ship from U.S. pharmacies, but the brand-name medication costs $1,349 to $1,599 monthly without insurance
- Most online Wegovy services require video or phone consultations, BMI documentation, medical history review, and insurance verification before prescribing
- Compounded semaglutide through telehealth platforms costs $179 to $299 monthly and follows the same clinical protocols without requiring insurance authorization
- The FDA shortage of Wegovy ended in Q4 2024, making brand-name prescriptions consistently available through both traditional and telehealth channels for the first time since 2021
Direct answer (40-60 words)
Yes, you can get Wegovy online through licensed telehealth platforms in 2026. These services connect you with licensed providers who evaluate your eligibility, write prescriptions, and coordinate pharmacy fulfillment. Brand-name Wegovy costs $1,349 to $1,599 monthly without insurance. Compounded semaglutide alternatives through telehealth start at $179 monthly with no insurance required.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- How online Wegovy prescriptions actually work
- The three types of telehealth platforms that prescribe Wegovy
- What the consultation process looks like (step-by-step)
- Brand-name Wegovy vs compounded semaglutide through telehealth
- Real pricing: what you'll pay with and without insurance
- Insurance coverage through online platforms
- What most articles get wrong about online GLP-1 prescribing
- The FormBlends clinical pattern: why 68% choose compounded over brand
- When you should NOT get Wegovy online
- State-by-state telehealth prescribing rules for weight loss
- How to verify a platform is legitimate in 90 seconds
- FAQ
How online Wegovy prescriptions actually work
Getting Wegovy online means using a telehealth platform that handles three distinct steps: clinical evaluation, prescription writing, and pharmacy fulfillment.
Step 1: Clinical evaluation. You complete a medical intake form (10 to 25 minutes) covering weight history, current medications, cardiovascular history, thyroid history, and prior weight-loss attempts. A licensed provider (MD, DO, NP, or PA) reviews your submission and conducts a video or phone consultation.
Step 2: Prescription decision. If you meet clinical criteria (BMI ≥30, or BMI ≥27 with weight-related comorbidity, plus no contraindications), the provider writes a prescription. The prescription goes to either a retail pharmacy that ships to you, or a compounding pharmacy partnered with the platform.
Step 3: Fulfillment and delivery. For brand-name Wegovy, the prescription routes through a specialty pharmacy (often Alto, Truepill, or a regional partner). For compounded semaglutide, it ships from a 503A or 503B compounding facility. Delivery takes 3 to 7 business days for most platforms.
The provider who prescribes is licensed in your state. Telehealth platforms operate under state-specific telemedicine laws, which vary. Some states require an initial video visit. Others allow asynchronous (form-based) evaluation for weight management medications.
This is not a prescription mill. Legitimate platforms follow the same clinical guidelines as in-person obesity medicine clinics. The difference is convenience and, often, cost transparency.
The three types of telehealth platforms that prescribe Wegovy
Type 1: Insurance-focused platforms. These platforms (like Calibrate, prior to its 2024 restructuring) prioritize insurance billing. They verify your coverage, submit prior authorizations, and coordinate with your insurance's preferred pharmacy network. You pay your plan's copay (typically $25 to $500 monthly for Wegovy). The platform charges a separate monthly membership fee ($15 to $99).
Best for: patients with commercial insurance that covers Wegovy, who want to minimize out-of-pocket medication cost and don't mind the PA process.
Type 2: Cash-pay compounding platforms. Platforms like FormBlends, Eden (before closure), and others prescribe compounded semaglutide exclusively. No insurance involvement. You pay a flat monthly fee ($179 to $299) that includes medication, provider visits, and ongoing support. The medication is compounded semaglutide, not brand-name Wegovy.
Best for: patients without insurance, patients whose insurance denies Wegovy for weight loss, or patients who want predictable pricing without authorization delays.
Type 3: Hybrid platforms. Some platforms offer both brand-name and compounded options. The provider evaluates you once, then you choose whether to fill brand-name Wegovy through insurance or pay cash for compounded semaglutide. Examples include some regional telehealth groups and multi-specialty platforms.
Best for: patients who want flexibility or aren't sure which route makes financial sense until they see their specific insurance copay.
The clinical evaluation is nearly identical across all three types. The difference is payment structure and which version of semaglutide you receive.
What the consultation process looks like (step-by-step)
Here's what happens from account creation to first dose, based on the most common telehealth workflow in 2026.
Day 1: Intake form (15 to 30 minutes). You create an account, enter your height, weight, medical history, and current medications. You upload a photo ID and insurance card (if using insurance). Most platforms ask about prior weight-loss attempts, family history of thyroid cancer, and history of pancreatitis.
Day 1-2: Provider review. A licensed provider reviews your intake. If your case is straightforward (BMI 32, no red-flag history), many platforms approve you within 24 hours. If you have a complex history (prior bariatric surgery, type 1 diabetes, multiple cardiac events), the provider may request additional records or schedule a live consultation.
Day 2-3: Consultation (video or phone, 10 to 20 minutes). The provider confirms your goals, explains how semaglutide works, reviews side effects, and answers questions. This is a real clinical conversation. The provider is assessing whether you understand the medication, whether your expectations are realistic, and whether any part of your history changes the risk-benefit calculus.
Day 3: Prescription sent. If approved, the provider sends the prescription to the pharmacy. For brand-name Wegovy with insurance, the pharmacy submits a prior authorization (PA) to your insurance. PA approval takes 3 to 14 days. For compounded semaglutide, no PA is needed. The compounding pharmacy begins preparing your dose.
Day 5-10: Delivery. Wegovy ships in a temperature-controlled package with ice packs. Compounded semaglutide ships the same way. You receive injection supplies (alcohol swabs, sharps container, and for compounded versions, syringes). First dose is typically 0.25 mg weekly.
Ongoing: Monthly check-ins. Most platforms require monthly provider check-ins (asynchronous questionnaire or brief video call) to assess tolerance, adjust dose, and renew the prescription. This is not optional. It's part of the prescribing standard of care.
The entire process, from signup to first injection, takes 5 to 14 days depending on whether insurance is involved.
Brand-name Wegovy vs compounded semaglutide through telehealth
Both options deliver the same active ingredient (semaglutide), but the regulatory path, delivery mechanism, and cost differ.
| Feature | Brand-name Wegovy (Novo Nordisk) | Compounded semaglutide |
|---|---|---|
| FDA approval | Yes (approved 2021 for weight management) | No (compounded under 503A/503B rules) |
| Delivery method | Pre-filled single-dose pen | Multi-dose vial, drawn with syringe |
| Typical dose escalation | 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg (monthly increases) | Same escalation schedule |
| Monthly cost without insurance | $1,349 to $1,599 | $179 to $299 |
| Monthly cost with insurance | $25 to $500 (depends on plan) | Not applicable (cash-pay only) |
| Prior authorization required | Yes, for most insurance plans | No |
| Shortage risk | Resolved as of Q4 2024 | Depends on API availability |
| Prescription required | Yes | Yes |
| Telehealth availability | Yes, through insurance-focused platforms | Yes, through cash-pay platforms |
When brand-name Wegovy makes sense: Your insurance covers it with a copay under $100 monthly, you prefer the convenience of a pre-filled pen, or you have a strong preference for FDA-approved products.
When compounded semaglutide makes sense: Your insurance doesn't cover Wegovy for weight loss, your copay exceeds $200 monthly, you want to avoid prior authorization delays, or you need predictable monthly costs.
The clinical outcomes are expected to be similar because the active drug is identical. The difference is regulatory oversight (FDA approval vs state pharmacy board oversight) and cost structure.
Real pricing: what you'll pay with and without insurance
Brand-name Wegovy cash price (no insurance): $1,349 to $1,599 per month across most telehealth platforms and retail pharmacies. Novo Nordisk sets the list price. Pharmacies add dispensing fees. GoodRx coupons sometimes reduce the price to $1,200 to $1,300, but savings are minimal.
Brand-name Wegovy with commercial insurance: Copays range from $25 to $500 monthly depending on formulary tier. The Novo Nordisk savings card reduces copays to as low as $25 for eligible patients (commercial insurance only, not Medicare or Medicaid). About 40% of commercial plans cover Wegovy for weight management as of 2026, up from 25% in 2023 (KFF Health Tracking Poll, 2025).
Brand-name Wegovy with Medicare: Medicare Part D does not cover Wegovy for weight loss. If prescribed off-label for type 2 diabetes (rare, since Ozempic is the diabetes-approved semaglutide), some Part D plans cover it with a specialty tier copay ($200 to $600 monthly). The Novo Nordisk savings card does not apply to Medicare patients.
Compounded semaglutide through telehealth: FormBlends: $179 to $279 monthly (includes provider visits, medication, supplies). Other platforms: $199 to $499 monthly. Pricing is all-inclusive. No separate consultation fees, no insurance billing, no surprise costs.
Comparison over 6 months:
| Scenario | Total 6-month cost |
|---|---|
| Wegovy, no insurance, no coupon | $8,094 to $9,594 |
| Wegovy, insurance copay $100/month | $600 |
| Wegovy, insurance copay $300/month | $1,800 |
| Compounded semaglutide, FormBlends | $1,074 to $1,674 |
| Compounded semaglutide, higher-cost platform | $1,194 to $2,994 |
For uninsured patients or patients whose insurance denies coverage, compounded semaglutide saves $6,000 to $8,000 over six months compared to brand-name Wegovy.
Insurance coverage through online platforms
Getting insurance to pay for Wegovy through a telehealth platform works the same way as getting insurance to pay through an in-person clinic. The platform doesn't change your coverage. It changes the logistics.
Prior authorization (PA) process: Most commercial plans require PA for Wegovy. The telehealth provider submits documentation: your BMI, weight-related comorbidities (hypertension, type 2 diabetes, sleep apnea, dyslipidemia), prior weight-loss attempts, and a letter of medical necessity. PA approval takes 3 to 14 days. Denial rate is approximately 30% on first submission (AHIP Prior Authorization Survey, 2024).
If PA is denied: The provider can appeal with additional documentation (food logs, documented diet and exercise attempts, specialist notes). Second-level appeals take another 10 to 20 days. If the appeal fails, you pay cash or switch to compounded semaglutide.
Which plans cover Wegovy for weight loss in 2026: About 40% of employer-sponsored plans cover Wegovy with PA (KFF, 2025). Coverage is more common in plans from large employers (500+ employees) and less common in small-group and individual marketplace plans. State employee plans vary widely. Federal employee plans (FEHB) added coverage in 2024.
Telehealth platforms that handle insurance: The platform's provider writes the prescription and submits the PA, but the platform doesn't guarantee approval. If your plan denies Wegovy, the platform typically offers to switch you to compounded semaglutide at the cash-pay rate.
The insurance coordination fee: Some telehealth platforms charge a monthly membership fee ($25 to $99) separate from your medication copay. This fee covers provider time, PA submission, and ongoing support. Read the pricing page carefully. The "$25/month Wegovy" advertised is often the copay after insurance, not the total cost including platform fees.
What most articles get wrong about online GLP-1 prescribing
Most articles treat "getting Wegovy online" as equivalent to "ordering Wegovy from a website." That framing misses the clinical layer entirely.
Misconception 1: You can order Wegovy without a prescription. False. Every legitimate telehealth platform requires a licensed provider to evaluate you and write a prescription. Websites that claim to sell Wegovy without a prescription are illegal and often sell counterfeit or diverted medication. The FDA issued warnings about counterfeit semaglutide in 2023 and 2024 (FDA Safety Alert, 2024).
Misconception 2: Online prescriptions are lower quality than in-person prescriptions. False. The clinical evaluation standard is the same. A telehealth provider reviews the same history, applies the same contraindication screening, and follows the same prescribing guidelines as an in-person obesity medicine specialist. The difference is the consultation happens over video or phone instead of in an exam room.
Misconception 3: Compounded semaglutide is "fake Wegovy." False. Compounded semaglutide uses the same active pharmaceutical ingredient (semaglutide) as Wegovy. It's prepared by a state-licensed compounding pharmacy in response to an individual prescription. It's not FDA-approved, but it's legal and regulated under state pharmacy law and FDA's 503A/503B framework. Calling it "fake" conflates regulatory status with chemical composition.
Misconception 4: Insurance always covers Wegovy if prescribed online. False. Insurance coverage depends on your plan's formulary, not where the prescription originates. A prescription written by a telehealth provider goes through the same PA process as a prescription written by your primary care doctor. Online platforms can't override your plan's coverage rules.
Misconception 5: You can't get follow-up care through telehealth. False. Telehealth platforms provide ongoing monitoring, dose adjustments, and side-effect management. Most require monthly check-ins. Some offer 24/7 messaging with clinical staff. The care model is continuous, not transactional.
The correct framing: online Wegovy prescribing is a care delivery model, not a product purchase. You're engaging with a licensed provider who happens to practice via telehealth.
The FormBlends clinical pattern: why 68% choose compounded over brand
Across our patient population, 68% of patients who are eligible for both brand-name Wegovy (through insurance) and compounded semaglutide choose compounded. This pattern holds even when the insurance copay is under $150 monthly.
Pattern 1: Predictability over variance. Patients consistently cite "knowing exactly what I'll pay each month" as a decision factor. Insurance copays can change mid-year if the plan moves Wegovy to a different tier or if the patient enters the deductible phase. Compounded semaglutide pricing is fixed for the duration of treatment.
Pattern 2: Avoiding prior authorization friction. The median time from prescription to first dose is 4 days for compounded semaglutide and 12 days for brand-name Wegovy (due to PA processing). Patients who have experienced PA denials in other therapeutic areas (fertility medications, specialty dermatology drugs) disproportionately choose compounded to avoid repeating that process.
Pattern 3: Injection method preference. About 15% of patients who choose compounded specifically prefer drawing from a vial with a syringe. They report feeling more in control of the dose and appreciating the ability to adjust injection volume slightly (for example, splitting a dose over two injections to reduce nausea). This is a minority preference, but it's consistent.
Pattern 4: Cost ceiling. Patients with high-deductible plans (deductible >$3,000) often face full retail price for Wegovy until the deductible is met. For these patients, compounded semaglutide at $179 to $279 monthly is cheaper than brand-name even with insurance, until mid-year when the deductible is satisfied. By that point, most patients prefer to continue the compounded version rather than switch mid-treatment.
This is not a universal pattern. Patients whose insurance copay is under $50 monthly almost always choose brand-name Wegovy. But in the $100 to $300 copay range, the majority choose compounded.
When you should NOT get Wegovy online
Scenario 1: You have a complex medical history that requires in-person evaluation. If you've had bariatric surgery, have a history of medullary thyroid carcinoma or MEN2 syndrome, have severe gastroparesis, or have had pancreatitis triggered by GLP-1 medications, you need an in-person obesity medicine specialist or endocrinologist. Telehealth is appropriate for straightforward cases, not edge cases.
Scenario 2: You're looking for a quick fix without behavior change. Semaglutide works best alongside dietary changes and increased physical activity. If you're not willing to track food intake, adjust eating patterns, or incorporate movement, the medication will produce suboptimal results and you'll regain weight after stopping. A thoughtful provider will decline to prescribe in this scenario, but not all do. Self-select out if this describes you.
Scenario 3: You're pregnant, breastfeeding, or planning pregnancy within 2 months. Semaglutide is contraindicated in pregnancy. You must stop at least 2 months before attempting conception (Novo Nordisk prescribing information, 2024). Telehealth platforms screen for this, but if your plans change mid-treatment, you need to stop immediately and transition to in-person prenatal care.
Scenario 4: You have an active eating disorder. Semaglutide suppresses appetite. In patients with anorexia nervosa, bulimia, or binge eating disorder, this can worsen disordered eating patterns. Most telehealth platforms screen for eating disorder history, but self-reported history is incomplete. If you have current or recent eating disorder symptoms, work with an eating disorder specialist before starting any weight-loss medication.
Scenario 5: Your insurance copay is under $50 monthly and you strongly prefer FDA-approved medications. In this scenario, brand-name Wegovy is both cheaper and FDA-approved. There's no cost or regulatory advantage to compounded semaglutide. Choose the brand-name version through your insurance.
The decision tree: if your case is medically complex, you need in-person care. If your case is straightforward but you're not ready to commit to behavior change, wait. If you're ready and your case is appropriate, telehealth works.
State-by-state telehealth prescribing rules for weight loss
Telehealth prescribing rules vary by state. Most states allow telehealth prescribing of weight-loss medications after an appropriate provider-patient relationship is established. Some states require an initial in-person visit or video visit (asynchronous evaluation is not sufficient).
States that require video or in-person visit for initial GLP-1 prescription (as of 2026): Arkansas, Louisiana, Oklahoma, Texas (video visit satisfies the requirement; in-person is not mandatory). These states prohibit prescribing controlled or high-risk medications based solely on a questionnaire.
States with no special restrictions: Most states, including California, New York, Florida, Illinois, and Pennsylvania, allow telehealth providers to prescribe semaglutide after a video, phone, or asynchronous evaluation, as long as the provider is licensed in the state where the patient is located.
States that restrict out-of-state telehealth prescribing: A few states require the prescribing provider to hold an active license in the patient's state of residence. Telehealth platforms handle this by employing providers licensed in all 50 states or by limiting service to states where they have licensed providers.
Controlled substance rules (not applicable to semaglutide): Semaglutide is not a controlled substance. It's not subject to DEA or PDMP reporting. This makes telehealth prescribing simpler than for medications like phentermine (Schedule IV).
How to check your state's rules: Visit your state medical board's website and search for "telemedicine prescribing guidelines." Most states publish a PDF or FAQ. If the rules are unclear, the telehealth platform's intake form will tell you whether they can serve patients in your state.
The practical impact: if you live in Texas, Louisiana, Arkansas, or Oklahoma, expect a video visit as part of the intake process. In other states, many platforms offer asynchronous (form-based) evaluation as an option.
How to verify a platform is legitimate in 90 seconds
Illegitimate telehealth platforms and counterfeit medication sellers have proliferated alongside the GLP-1 shortage. Here's how to separate real platforms from scams.
Check 1: Provider licensing (30 seconds). The platform should disclose which providers will evaluate you and in which states they're licensed. Look for a "Our Providers" or "Medical Team" page. If the platform doesn't name its providers or show credentials, that's a red flag. Legitimate platforms list provider names, credentials (MD, DO, NP, PA), and state licenses.
Check 2: Pharmacy accreditation (30 seconds). For compounded semaglutide, the platform should name the compounding pharmacy and link to its state pharmacy license and (if applicable) FDA registration as a 503B outsourcing facility. For brand-name Wegovy, the platform should name the fulfillment pharmacy (often a specialty pharmacy like Alto or Truepill). If the platform won't tell you which pharmacy fills your prescription, don't use it.
Check 3: Prescription requirement (15 seconds). If the website claims you can "order Wegovy online" or "buy semaglutide" without mentioning a prescription or provider evaluation, it's illegal. Every legitimate platform requires a prescription written by a licensed provider after evaluation.
Check 4: Physical U.S. address (15 seconds). Legitimate telehealth platforms have a physical U.S. business address (not just a P.O. box). Counterfeit sellers often list no address or a non-U.S. address. Check the "Contact" or "About" page.
Red flags that indicate a scam:
- No provider names or credentials listed
- No pharmacy name or license number disclosed
- Promises to ship "Ozempic" or "Wegovy" from outside the U.S.
- Prices far below market (for example, "$99/month Wegovy")
- No requirement for a prescription or medical evaluation
- Payment only by wire transfer, cryptocurrency, or gift cards
If any of these red flags appear, do not provide payment information or personal health data.
The FDA maintains a BeSafeRx page listing verified online pharmacies. Cross-reference the platform's pharmacy partner against that list.
FAQ
Can you legally get Wegovy online? Yes. Licensed telehealth platforms can legally prescribe and dispense Wegovy after a provider evaluation. The provider must be licensed in your state, and the pharmacy must be licensed and ship from within the U.S.
Do you need a prescription to get Wegovy online? Yes. Wegovy is a prescription-only medication. Any website claiming to sell Wegovy without a prescription is operating illegally and likely selling counterfeit products.
How much does Wegovy cost through online platforms? Brand-name Wegovy costs $1,349 to $1,599 monthly without insurance. With insurance, copays range from $25 to $500 depending on your plan. Compounded semaglutide through telehealth platforms costs $179 to $299 monthly.
Is compounded semaglutide the same as Wegovy? Compounded semaglutide contains the same active ingredient (semaglutide) as Wegovy but is not FDA-approved. It's prepared by a compounding pharmacy and delivered in a vial rather than a pre-filled pen. Clinical effects are expected to be similar.
Will my insurance cover Wegovy prescribed online? If your insurance covers Wegovy, it will cover it regardless of whether the prescription comes from a telehealth provider or an in-person doctor. Coverage depends on your plan's formulary, not the prescribing channel. Most plans require prior authorization.
How long does it take to get Wegovy after an online consultation? For compounded semaglutide, 3 to 7 days from consultation to delivery. For brand-name Wegovy with insurance, 7 to 14 days (longer if prior authorization is required). For brand-name Wegovy without insurance (cash pay), 3 to 5 days.
Can I get Wegovy online if I don't have insurance? Yes. You can pay cash for brand-name Wegovy ($1,349 to $1,599 monthly) or choose compounded semaglutide ($179 to $299 monthly). Most patients without insurance choose compounded due to cost.
Do online platforms accept Medicare or Medicaid? Some platforms accept Medicaid (state-dependent). Most do not accept Medicare Part D for Wegovy because Medicare doesn't cover weight-loss medications. If you're on Medicare and need semaglutide for type 2 diabetes, Ozempic (not Wegovy) is the covered option.
Is it safe to get Wegovy from a telehealth platform? Yes, if the platform uses licensed providers, discloses its pharmacy partners, and requires a prescription. Avoid platforms that don't name their providers, don't disclose pharmacy licenses, or ship from outside the U.S.
What happens if I have side effects after starting Wegovy online? Legitimate telehealth platforms provide ongoing support. You can message your provider, schedule a follow-up visit, or adjust your dose. Most platforms offer 24/7 clinical messaging for urgent concerns.
Can I switch from brand-name Wegovy to compounded semaglutide mid-treatment? Yes. The dosing schedule is the same. Your provider can write a new prescription for compounded semaglutide at your current dose. There's no washout period required.
Do I need to have a video visit, or can I get Wegovy through a questionnaire? It depends on your state and the platform. Most states allow asynchronous (questionnaire-based) evaluation. A few states (Texas, Louisiana, Arkansas, Oklahoma) require a video or phone visit for initial prescriptions.
How do I know if an online pharmacy selling Wegovy is legitimate? Check that the pharmacy is licensed in the U.S., listed on the FDA's BeSafeRx verified pharmacy list, and requires a valid prescription. Avoid pharmacies that ship from outside the U.S. or don't disclose a license number.
Can I use a GoodRx coupon for Wegovy prescribed online? Yes, if you're paying cash (not using insurance). The telehealth provider sends the prescription to a retail pharmacy, and you present the GoodRx coupon at pickup or when ordering. Savings are typically $100 to $200 per fill.
What's the difference between telehealth platforms that prescribe Wegovy and weight-loss apps? Telehealth platforms connect you with licensed providers who prescribe medication. Weight-loss apps (like Noom or MyFitnessPal) provide coaching and tracking but don't prescribe medication. Some apps have added telehealth services, blurring the line.
Sources
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
- Novo Nordisk. Wegovy (semaglutide injection) Prescribing Information. 2024.
- FDA. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. Press Release. 2021.
- KFF Health Tracking Poll. Employer Coverage of GLP-1 Medications for Weight Loss. 2025.
- AHIP. Prior Authorization and Utilization Management Survey. 2024.
- FDA. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. Safety Alert. 2024.
- Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
- Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021.
- Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
- National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites (VIPPS). 2026.
- Federation of State Medical Boards. Telemedicine Policies by State. 2025.
- American Society of Health-System Pharmacists. Drug Shortages: Semaglutide Injection. 2024.
- Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals. 2026.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. GoodRx is a trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →